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A B S T R A C T
Endemic nephropathy is a chronic tubulointerstitial disease characterized by early damage to the proximal tubule,
with low-molecular weight proteinuria being an important hallmark and possible tool for early diagnosis. The aim of
this retrospective cohort study was to assess the risk of developing endemic nephropathy in subjects with proteinuria
from the endemic region in Croatia. The cohort study included subjects with proteinuria determined by the sulfosalicylic
acid method (after 1988 with strip method), involved in the field survey conducted in the Croatian endemic village of
Kani`a in 1975 and followed up until 1997. Subjects with endemic nephropathy established at the first visit and patients
that failed to present for follow up visits after 1975. were excluded. In the field survey group that consisted of 624 subjects
(286 male and 338 female), proteinuria was established in 157 subjects. Upon the application of exclusion and inclusion
criteria, the study cohort included 111 of 157 subjects. The mean follow up was 7.26 years (95% confidence interval
4.06–10.46 years). During the follow up period, 19 (17%) subjects with initial proteinuria developed endemic nephro-
pathy. The incidence density of endemic nephropathy among subjects with proteinuria was 1.3 per 100 persons/year. Esti-
mated risk was 0.0137 (confidence interval 0.0087–0.0214) per year of exposure. The presence of proteinuria determined
by the sulfosalicylic acid or test strip in subjects from the endemic village indicated that endemic nephropathy would de-
velop in 1.3 of 100 subjects with proteinuria per year.
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Introduction
Endemic (Balkan) nephropathy (EN) is a chronic
tubulointerstitial disease with insidious onset and a slow
but progressive clinical course eventually leading to
chronic renal failure1,2. EN has been recorded only in
farming villages located near big tributaries of the Dan-
ube River in Bosnia and Herzegovina, Bulgaria, Croatia,
Romania and Serbia. In Croatia, it has been found in 14
villages to the west of Slavonski Brod, which is situated
in the eastern part of inland Croatia1.
EN is also strongly associated with upper urothelial
cancers. In the endemic area, the specific mortality rate
of upper urothelial cancer has been 55-fold that recorded
at the national level3. An increased mortality rate of up-
per urothelial cancers in endemic versus non-endemic ar-
eas has also been reported from other countries4. Over
years, numerous etiologic hypotheses including myco-
toxins, infectious agents, heavy metals and genetic pre-
disposition have been investigated5–10. Most recently, the
results reported by a Croatian/US team of investigators
have pointed to aristolochic acid from Aristolochia clema-
titis as the etiologic factor for EN, with the possible gene-
tic factors involved in the respective susceptibility5,11–14.
The first epidemiological field survey in the Croatian
endemic area was conducted in 1957 in the villages of
Pri~ac and Bebrina15. Since that time, field surveys have
been carried out periodically in endemic and a few non-
-endemic villages. In the endemic village of Kani`a, sur-
vey was conducted continuously from 1975 to 1997, and
was interrupted only in 1992 due to the war in Croatia.
Surveys were much less frequently performed in other
villages of the Croatian endemic area, with just a single
survey being carried out in some villages15,16.
155
Received for publication June 19, 2012
The World Health Organization (WHO) established
diagnostic criteria for the diagnosis of EN and classifica-
tion of the population at risk17. These criteria have been
validated and refined by several research groups in order
to enable more precise diagnosis of the disease early in its
course18–20.
There is no specific diagnostic marker of EN. Urine
analysis is very important in the diagnosis of EN. Pro-
teinuria is one of the major EN features and an essential
diagnostic marker. In the last few decades, proteinuria
has been defined as low-molecular weight tubular pro-
teinuria due to an early proximal tubule lesion. In the
early stage of the disease, proteinuria is mild, intermit-
tent, and characterized by excretion of low-molecular
weight protein. This was recognized even in the first sur-
veys carried out in the 1960s, when proteinuira was de-
termined by the sulfosalicylic acid method and later by
use of test strip. Significantly higher rates of proteinuria
have been found in the population living in the endemic
area as compared with those living out of endemic villa-
ges21–24.
Although proteinuria is an important component of
the disease, and suggested as a possible early marker of
EN, the risk of developing EN in individuals with pro-
teinuria identified by screening testing has not yet been
evaluated. EN develops in some but not all patients with
proteinuria from the Croatian endemic area. Thus, the
aim of this study was to assess the risk of developing EN
in subjects with proteinuria living in an endemic area.
Subjects and Methods
This retrospective cohort study included subjects in-
volved in the field study carried out in the Croatian en-
demic village of Kani`a in 1975. A total of 624 subjects
were followed-up yearly until 1997, with the exception of
1992 due to the war in Croatia. Systematic annual sur-
veys in the village of Kani`a have not been performed
since 1997. In the 1975 field survey, all inhabitants older
than 3 years were invited to participate in the door-to-
-door survey. The data collected were stored at the Public
Health Institute of the Brod-Posavina County in Slavon-
ski Brod, containing the following information: fam-
ily/household history of EN, personal history of chronic
diseases, occupation, year of birth, sex, period living in
endemic area, proteinuria, serum creatinine and hemo-
globin levels. According to the modified WHO criteria,
currently used in Croatia, the following diagnostic mark-
ers for subjects living in an endemic area were used: (a)
positive family/household history of EN; (b) low weight
proteinuria; (c) serum creatinine concentration >132.7
mmol/L; (d) anemia (Hb <120 g/L in men and Hb <113
g/L in women); and (e) exclusion of all other chronic re-
nal diseases. Using these markers, subjects are classified
into one of five groups as follows: group 1 – established
EN includes the following marker combinations: a+b+
+c+d+e, or b+c+d+e, or a+b+d+e; group 2 – suspect
of having EN includes the following marker combina-
tions: a+b+e, or b+d+e; group 3 – subjects at risk of
having EN have the following marker: a; group 4 – sub-
jects free from EN are negative for the following mark-
ers: a, b, c and d; and group 5 – unclassified.
Proteinuria was determined by the method of sulfo-
salicylic acid (>0.2 g/L) until 1987, and by test strip
(>0.3 g/L) (Urocomb 9, Pliva, Zagreb, Croatia) from 1988
to 1997. The inclusion criterion for this analysis was pos-
itive screening test for proteinuria at the beginning of
follow up in 1975. Out of 624 subjects, 157 were positive
for proteinuria. Subjects with established EN at baseline
were excluded. Out of 157 subjects positive for protein-
uria, 37 subjects met the WHO criteria for EN at the be-
ginning of the follow up period. Nine subjects that failed
to present for follow up examinations after 1975 were
also excluded irrespective of the reason; thus, the study
cohort included 111 subjects. They were followed-up
from 1975 to the time of EN development, withdrawal
from the study, or study completion in 1997.
Statistics
Because of different follow up period for each subject
in the study cohort, incidence density was used to calcu-
late the risk of developing EN in subjects with protein-
uria at baseline. Incidence density (ID) was calculated ac-
cording to the equation: Risk = 1–exp (–ID x follow up
period), where ID is incidence density in person/year25.
With the assumption that the rate is constant over time,
the risk is calculated with the corresponding 95% confi-
dence interval (CI). As time to the onset of EN varied
during follow up of patients with proteinuria, the risk
could not be calculated directly but had to be assessed by
use of incidence density.
Results
Basic demographic characteristics of study subjects
with proteinuria are shown in Tables 1 and 2.
The 1975 field study included 624 subjects (286 male
and 338 female) of 884 inhabitants then living in the vil-
lage, yielding a 70.6% rate of response. The prevalence of
proteinuria was 25%. In 1975, the diagnosis of EN ac-
cording to the WHO criteria was made in 37 subjects;
thus, the prevalence of EN in the village of Kani`a was
5.9%. Upon exclusion of subjects with established EN
and those that did not present for follow up examinations
after 1975, there were 111 subjects with proteinuria. Ac-
cording to the WHO criteria, 19 of these 111 subjects de-
veloped EN during the follow up period (arithmetic mean
7.26 years; 95% CI 4.06–10.46 years). Nineteen of 111
study subjects with proteinuria were followed up for
1378 years in total before developing EN, yielding the in-
cidence density of EN; the incidence of subjects with
proteinuria was 1.3 per 100 persons/year.
The risk of developing EN within a certain time in
subjects positive for proteinuria and living in the en-
demic area with corresponding 95% CI is shown in Table
3 and Figure 1.
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Discussion
Field studies regularly carried out annually in the
Croatian endemic area covered only the village of Kani`a
during the 1975–1997 period, with the only interruption
in 1992 due to the war in Croatia. During that period,
only one field survey was carried out in some villages
(Zbjeg, @ivike and Dubo~ac) to nine surveys having been
conducted in the village of Bebrina1,26,27. Since 1997, only
one field survey was carried out in the endemic village of
Kani`a, in 200528. Epidemiological characteristics of stu-
dy patients did not differ substantially from other litera-
ture reports28–32. Interestingly, in our study cohort we
identified a subject who developed EN at the age of 17,
and another one who developed EN after 10 years spent
in the EN area.
Another interesting observation was age difference
between the EN group and group of subjects that did not
develop EN during follow up period. Reason for this
could be that children were also recruited in the 1975
field survey. The possible reasons for some people having
refused to take part in the field survey could be joining
the army, work out of Kani`a, etc. According to literature
reports, more women then men develop EN33,34.
The highest prevalence of EN of 8.3% was recorded in
the endemic village of Pri~ac in 19771. In the village of
Kani`a, the prevalence of EN ranged from 4.4% in 1975
to 0.6% in 20051,28. During the 1975–1997 period, the an-
nual incidence of EN ranged from 4.9‰ in 1997 to 0‰ in
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TABLE 1
BASIC DEMOGRAPHIC CHARACTERISTICS OF STUDY COHORT (SUBJECTS WITH PROTEINURIA)
Endemic nephropathy developed during follow up
Total
Yes No
n % n % n %
Gender
Male 6 5.4 43 38.7 49 44.1
Female 13 11.7 49 44.1 62 55.9
Place of birth
Endemic village 16 14.4 64 57.7 80 72.1
Elsewhere 3 2.7 28 25.2 31 27.9
Family history of
endemic nephropathy
Positive 5 4.5 33 29.7 38 34.2
Negative 14 12.6 59 53.2 73 65.8
TABLE 2
EPIDEMIOLOGICAL CHARACTERISTICS OF SUBJECTS WITH PROTEINURIA INCLUDED IN FOLLOW UP




Standard deviation 14.77 22.97
95% CI 44–58 35–44
Median 52 40.5
Range 14–76 8–92
Age at endemic nephropathy diagnosis
or follow up completion (yrs)
X 58.3 52.8
Standard deviation 14.62 22.28





















Fig. 1. Risk of developing endemic nephropathy in subjects with
proteinuria and respective 95% confidence interval (CI).
198516,28. In this study, the prevalence of proteinuria was
25% in 1975, whereas the reported prevalence of protein-
uria determined by the sulfosalicylic acid method in the
endemic area in Serbia was 15.9%35. Determination of
proteinuria using sulfosalicylic acid and test strip as a
nonspecific method was a limitation of the present study.
However, this method had for years been used not only as
a basic screening method, but as one of diagnostic crite-
ria. In the last several decades, more precise markers of
proximal tubular damage have been developed and used
in Croatia since the early 1990s. Positive finding of
proteinuria is defined as beta2-microglobulinuria >0.3
mg/L and alpha1-microglobulinuria >10 mg/L21.
To the best of our knowledge, there are no literature
reports on such an approach in assessing the risk of de-
veloping EN in patients with proteinuria. In the present
study, regular annual field surveys carried out in a single
endemic village in Croatia over a 23-year period were an-
alyzed. Despite relatively small population of EN cases,
and evidence that prevalence of EN in the endemic Cro-
atian areas appears to be decreasing28,30 assessing the
risk of EN with the assumption that the rate is constant
over time has yielded valuable information for planning
public health actions, and indicating the need of addi-
tional field surveys to clarify possible risk changes over
time.
In the village of Kani`a, the EN incidence density in
individuals with proteinuria was 1.3 per 100 individuals
with proteinuria per year. Very few studies report inci-
dence density or other measures of risk of EN. However,
studies conducted in Serbia report the mortality rates
with or from EN during the 1974–1988 period to be 3.3
per 1000 persons/year and incidence rate of upper uro-
thelial tumors 1.4 per 1000 persons/year36,37. Patients
with beta2-microglobulinuria have a 9.9-fold relative risk
of EN development recorded in subjects without beta2-
-microglobulinuria36. In our study, the risk increased
with the years of living in the endemic area (Fig. 1). In
another study, 10 of 48 subjects (20.8%) with beta2-mi-
croglobulinuria and 17% of subjects with proteinuria de-
veloped EN38. However, the results obtained in this study
showed that 1.3 subjects per 100 individuals with pro-
teinuria established by the sulfosalicylic acid method de-
veloped EN per year.
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RIZIK RAZVOJA ENDEMSKE NEFROPATIJE U OSOBA S PROTEINURIJOM
U ENDEMSKOM PODRU^JU
S A @ E T A K
Endemska nefropatija je kroni~na tubulointersticijska bolest karakterizirana o{te}enjem proksimalnog tubula. Pro-
teinurija je va`an dijagnosti~ki znak i mogu}i biljeg za ranu dijagnozu. Cilj ove retrospektivne studije je prikazati rizik
razvoja endemske nefropatije kod osoba s proteinurijom u endemskom podru~ju u Hrvatskoj. U studiju su uklju~ene
sve osobe s proteinurijom utvr|enom sulfosalicilnom kiselinom pri terenskom istra`ivanju u endemskom selu Kani`a
1975. godine. Te osobe su pra}ene do 1997.godine. Osobe s proteinurijom koje su 1975. godine imale endemsku nefro-
patiju su isklju~ene kao i one koje se nisu kasnije javljale na pregled. Proteinurija je utvr|ena u 157 od 624 osobe pri
prvom pregledu u endemskom selu Kani`a. Nakon primjene isklju~uju}ih kriterija ostalo je od 157 osoba s protein-
urijom, 111 osoba koji su prosje~no pra}eni 7,26 godina (95% CI 4,06–10,46 godina). Za vrijeme perioda pra}enja kod 19
(17%) osoba se razvila endemska nefropatija. Procijenjeni rizik je bio 0.0137 (CI 0,0087–0,0214) za svaku godinu izlo-
`enosti. U osoba s proteinurijom utvr|enom sulfosalicilnom kiselinom u endemskim selima endemska nefropatija se
razvije u 1,3 osobu od 100 osoba s proteinurijom godi{nje.
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